SKAI Ventures is continuously adding companies and technologies to its’ portfolio. SKAI Ventures is actively developing several suites of disruptive technologies in various stages of maturity.
- Eye Surgery Center
- Eyegenix
- SKAI Vision Institute
- CBI Polymers
- TruTags
- Cellular Bioengineering Inc.
- StemPure
- CMC Chip
- World Children’s Vision 501 (c) 3
Interested in becoming the next? Contact us.
